How do you obtain the approval to quickly launch a clinical trial in 13 African countries while ensuring that the most stringent ethical standards are respected?

Delese Mimi Darko, Chief Executive Officer, Food and Drugs Authority of Ghana, Dr Diadié Maïga, Regional Vaccine Regulatory Officer at the World Health Organization Regional Office for Africa, and Dr Nathalie Strub-Wourgaft, Director of the COVID-19 Response at DNDi explain the role that the African Vaccine Regulatory Forum played in approving the #ANTICOV trial.

The ANTICOV trial: [ Ссылка ]
DNDi's work on #COVID19: [ Ссылка ]

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients' needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases. [ Ссылка ]

свернуть